- TV Footage
- Financial Reports
- Newsletter Overview
- Social Media
- Media Contact
Leverkusen/Berlin, November 27, 2017 – Bayer is deepening its ties with Bitkom, Germany's digital association, and is bolstering its support for digital innovation in the areas of health care and agriculture. As a member of the largest digital association in Germany, Bayer will focus on digital transformation, e-health and digital farming, and will be an active contributor in a variety of forums and initiatives. First of all, Bayer will discuss “Innovation for Digital Health” at Bitkom's hub.berlin conference on November 28, 2017.
“Bayer is pressing ahead with the digital transformation. We are focusing on expanding the digitalization of all of our external business relationships – especially with our customers, suppliers, partners, and on developing new digital business models and digitalizing all business processes,” says Daniel Hartert, Bayer AG's Chief Information Officer. “Our steadily increasing activities in Bitkom represent one aspect of our external engagement.”
“Digitalization has enormous potential in health care and agriculture,” says Dr. Bernhard Rohleder, CEO of Bitkom, reinforcing this point. “That's why we are pleased to welcome Bayer, the leading life science company in our association, and to tackle the digital issues of the future together.”
Under the brand name xarvio™, Bayer currently offers digital farming solutions in over 60 countries – solutions that make farming faster, more precise, more efficient and more sustainable. In the area of health care, Bayer is emphasizing three key elements: excellence in research and development, deploying groundbreaking technologies, and partnerships and open innovation.
In order to actively shape the potential of digitalization, Bayer is relying not only on its involvement with Bitkom, but also on its own open innovation activities and cooperative agreements with startups, universities and digital experts throughout the world. For example, Bayer is also a founding partner and life science partner of CUBE, the global innovation network headquartered in Berlin. In 2013, Bayer initiated its own crowdsourcing program, Grants4Apps, that has gone on to achieve global success. In collaboration with technology partners, Bayer is developing new digital ideas and solutions for the life science business at its LifeScience iHUB in Silicon Valley.
On November 28, 2017, Dirk Schapeler, head of LifeScience iHUB at Bayer, will discuss “Innovation for Digital Health” in the Transformers Arena at the hub.berlin business festival in Berlin. hub.berlin is organized by the digital association Bitkom and focuses on the digitalization of the economy, disruptive business models, technologies and startups.
Additional information can be found on the Bayer website under Digital Innovation: https://www.bayer.com/en/bayer-lifescience-ihub.aspx
Bitkom represents more than 2,500 companies involved in the digital economy, 1,700 of which are direct members. With over 700,000 employees, these companies achieve EUR 140 billion in sales per year and are responsible for another EUR 50 billion in exports. Members include 1,000 medium-sized businesses, more than 400 startups, and nearly all global players. They offer software, IT services, telecommunications or internet services; manufacture hardware or consumer electronics; are active in digital media or the network industry; or are a part of the digital economy in some other way. Seventy-nine percent of the companies have their headquarters in Germany, another nine percent come from Europe, and eight percent from the United States. Four percent come from Asia, with the majority from Japan. Bitkom supports the digital transformation of the German economy and advocates an innovative economic policy, modernization of the education system, and a forward-looking internet policy.
Bayer: Science For A Better Life
Bayer is a global enterprise with core competencies in the Life Science fields of health care and agriculture. Its products and services are designed to benefit people and improve their quality of life. At the same time, the Group aims to create value through innovation, growth and high earning power. Bayer is committed to the principles of sustainable development and to its social and ethical responsibilities as a corporate citizen. In fiscal 2016, the Group employed around 99,600 people and had sales of EUR 34.9 billion. Capital expenditures amounted to EUR 2.2 billion, R&D expenses to EUR 4.4 billion. For more information, go to www.bayer.com.
This release may contain forward-looking statements based on current assumptions and forecasts made by Bayer management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer’s public reports which are available on the Bayer website at www.bayer.com. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.